EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Artificial intelligence in diabetes mellitus: a tertiary review of the current landscape and future research directions

Sander M. W. Janssen, Yamine Bouzembrak, Maarten Cuypers, Bedir Tekinerdogan, Geraline Leusink

Frontiers in Endocrinology · 17.11.2026 · 17

DOI: 10.3389/fendo.2026.1933129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Endocrinology, online erschienen am 17.11.2026. Verfasst von Sander M. W. Janssen und 4 weiteren Autor:innen. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerie van Volksgezondheid, Welzijn en Sport.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Artificial intelligence (AI) is transforming diabetes mellitus (DM) care by enabling earlier detection, precision management, and data-driven decision support across clinical settings. However, the growing number of systematic reviews has produced a fragmented evidence base, making it difficult to assess the field’s maturity, methodological quality, and clinical readiness, and leaving future research directions largely undefined. To clarify this landscape, we conducted a tertiary review that synthesizes 70 systematic reviews on AI applications across type 1, type 2, and gestational diabetes and their major complications. Our analysis reveals an accelerating research trajectory since 2020, yet activity remains concentrated in type 1 and type 2 diabetes and in image-based applications such as diabetic retinopathy and foot-ulcer screening, with gestational and kidney disease still underexplored. Methodological rigor is inconsistent, with wide variation in search coverage, quality appraisal, and reporting standards. Across the literature, recurrent challenges include data bias, limited external validation, and barriers to clinical implementation. By integrating evidence across disease types, data modalities, and levels of care, this review shows that AI in diabetes is at a transitional stage. The field is technically advanced yet remains clinically fragmented and lacks a coherent roadmap for translation into practice. Expanding research into underrepresented areas such as multimodal data integration, natural-language processing of clinical text, and reinforcement learning for adaptive decision support will be essential to bridge this gap. This synthesis consolidates over a decade of secondary evidence and clarifies the structural and methodological requirements for achieving trustworthy, equitable, and scalable AI-driven diabetes care.

Förderung

  • Ministerie van Volksgezondheid, Welzijn en Sport

Zitieren

APA

Janssen, S. M. W., Bouzembrak, Y., Cuypers, M., Tekinerdogan, B., & Leusink, G. (2026). Artificial intelligence in diabetes mellitus: a tertiary review of the current landscape and future research directions. Frontiers in Endocrinology, 17. https://doi.org/10.3389/fendo.2026.1933129

Vancouver

Janssen SMW, Bouzembrak Y, Cuypers M, Tekinerdogan B, Leusink G. Artificial intelligence in diabetes mellitus: a tertiary review of the current landscape and future research directions. Frontiers in Endocrinology. 2026;17. doi:10.3389/fendo.2026.1933129

BibTeX
@article{Janssen2026,
  author = {Janssen, Sander M. W. and Bouzembrak, Yamine and Cuypers, Maarten and Tekinerdogan, Bedir and Leusink, Geraline},
  title = {Artificial intelligence in diabetes mellitus: a tertiary review of the current landscape and future research directions},
  journal = {Frontiers in Endocrinology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fendo.2026.1933129}
}
Kostenlos starten →